The three most common indications for lung transplantation were interstitial lung disease (42.4%), chronic obstructive pulmonary disease (34.2%) and alpha-1 antitrypsin deficiency (6.6%), although cystic fibrosis was also a common indication in the younger patients. Here, SERPINA1 is linked to cystic fibrosis.